Zobrazeno 1 - 10
of 154
pro vyhledávání: ''
Publikováno v:
Leuk Lymphoma
Relapsed/refractory Primary Central Nervous System Lymphoma (R/R PCNSL) has a poor prognosis with no established preferred treatment. We report the efficacy and toxicity of a combination chemotherapy regimen: methotrexate, carmustine, etoposide, and
Publikováno v:
Leukemia & Lymphoma. 61:2998-3001
Prophylactic use of granulocyte colony-stimulating factors (G-CSFs) reduces the risk of febrile neutropenia (FN) and is indicated for high-risk patients, such as elderly patients with B-cell non-Ho...
Autor:
Ronit Gurion, Uri Rozovski, Uri Abadi, Pia Raanani, Lee Peled, Martin Ellis, Pnina Rotman-Pikielny
Publikováno v:
Leukemia & Lymphoma. 60:2922-2926
The reported prevalence of hypercalcemia at diagnosis in non-Hodgkin-lymphoma ranges between 1.3% and 7.4%. These studies included all patients, regardless of lymphoma subtype. We performed a retrospective case-control study to determine the prevalen
Autor:
Labrador, Jorge, Luno, Elisa, Vellenga, Edo, Brunet, Salut, Gonzalez-Campose, Jose, Chillon, Maria C., Holowiecka, Aleksandra, Esteve, Jordi, Bergua, Juan, Gonzalez-Sanmiguel, Jose D., Gil, Cristina, Tormo, M., Salamero, Olga, Manso, Felix, Fernandez, Isolda, de laSerna, Javier, Moreno, Maria-Jose, Perez-Encinas, M., Krsnik, Isabel, Ribera, Josep-Maria, Cervera, Jose, Calasanz, Maria J., Boluda, Blanca, Sobas, Marta, Lowenberg, Bob, Sanz, Miguel A., Montesinos, Pau, Palmer, L., Fernandez, Ciarlo, S., Bezares, F., Rojas, F., Longoni, H., Gelemur, M., Fazio, P., Canepa, C., Saba, S., Balladares, G., Negri, P., Giunta, M., Milone, J., Prates, M., Lafalse, D., Sossa, C., Jaramillo, F., Mayer, J., Ramos, F., Martinez, J., de Groot, M. R., Schouten, H. C.
Publikováno v:
LEUKEMIA & LYMPHOMA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Leukemia & Lymphoma, 60(5), 1146-1155. Informa Healthcare
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Leukemia & Lymphoma, 60(5), 1146-1155. TAYLOR & FRANCIS LTD
Leukemia & Lymphoma, 60(5), 1146-1155. Routledge/Taylor & Francis Group
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Leukemia & Lymphoma, 60(5), 1146-1155. Informa Healthcare
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Leukemia & Lymphoma, 60(5), 1146-1155. TAYLOR & FRANCIS LTD
Leukemia & Lymphoma, 60(5), 1146-1155. Routledge/Taylor & Francis Group
Although additional cytogenetic abnormalities (ACA) do not affect the prognosis of patients with t(15;17) acute promyelocytic leukemia (APL), the role of a complex karyotype (CK) is yet to be clarified. We aimed to investigate the relationship of CK
Autor:
Sobas, Marta, Montesinos, Pau, Boluda, Blanca, Bernal, Teresa, Vellenga, Edo, Nomdedeu, Josep, Gonzalez-Campos, Jose, Chillon, Maria, Holowiecka, Aleksandra, Esteve, Jordi, Bergua, Juan, David Gonzalez-Sanmiguel, Jose, Gil-Cortes, Cristina, Tormo, M., Salamero, Olga, Manso, Felix, Fernandez, Isolda, de la Serna, Javier, Moreno, Maria-Jose, Perez-Encinas, Manuel, Krsnik, Isabel, Ribera, Josep-Maria, Escoda, Lourdes, Lowenberg, Bob, Angel Sanz, Miguel, Beltran de Heredia, J. M., Hernandez, J. M., Arias, J., Ramos, F., Roman, A., de la Serna, J., Negri, S., Rayon, C., Esteve, J., Fernandez-Calvo, F. J., Diaz-Mediavilla, J., Gil, C., Olave, M., Amutio, E., Pedro, C., Gorosquieta, A., Viguria, M., Zudaire, M., Molero, T., Sayas, M. J., Guardia, R., Martinez, J., de Groot, M. R., Schouten, H. C.
Publikováno v:
Leukemia & Lymphoma, 60(4), 1030-1035. Informa Healthcare
Leukemia & Lymphoma, 60(4), 1030-1035. TAYLOR & FRANCIS LTD
Leukemia & Lymphoma, 60(4), 1030-1035. Routledge/Taylor & Francis Group
Leukemia & Lymphoma, 60(4), 1030-1035. TAYLOR & FRANCIS LTD
Leukemia & Lymphoma, 60(4), 1030-1035. Routledge/Taylor & Francis Group
Out of 956, there were 95 (10%) CD56+ APL patients treated with PETHEMA ATRA and chemotherapy. CD56+ expression was associated with high WBC, BCR3 isoform, and co-expression of CD2, CD34, CD7, HLA-DR, CD15, and CD117 antigens. CD56+ vs CD56- APL pres
Autor:
Michael Roost Clausen, Alexander Lindholm d'Amore, Peter Kamper, Maja D. Andersen, Francesco d'Amore, Hans Bentzen
Publikováno v:
Andersen, M D, Kamper, P, d’Amore, A, Clausen, M, Bentzen, H & d'Amore, F 2018, ' The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor † ', Leukemia and Lymphoma . https://doi.org/10.1080/10428194.2018.1515939
In Hodgkin lymphoma (HL) bleomycin can induce pulmonary toxicity (BPT). BPT consists of respiratory tract symptoms during bleomycin-exposure and radiologic pulmonary lesions without concomitant infection. Older age, bleomycin dose, smoking history an
Autor:
Hubert H. Chuang, Chelsea C. Pinnix, Donald Hancock, N. George Mikhaeel, Sarah A. Milgrom, Andrew Wirth, Michalis Aristophanous, Mary Pham, Loretta J. Nastoupil, Bouthaina S. Dabaja, Yasuhiro Oki, Ethan B. Ludmir, Michelle A. Fanale, T.Y. Andraos, Jillian R. Gunther
Publikováno v:
Leukemia & Lymphoma. 59:2650-2659
Cardiophrenic lymph nodes (CPLNs) are occasionally involved in Hodgkin lymphoma (HL). We characterized the incidence of CPLN involvement among 169 HL patients and evaluated outcomes after treatment with omission of the CPLN region from the involved-s
Autor:
Daryl Tan, Yuh Shan Lee, Soon Thye Lim, Tiffany Tang, Colin Phipps, Alan Z Goh, Heng Joo Ng, Aditi Ghosh, Yunxin Chen, Yvonne Loh, Sathish Kumar Gopalakrishnan, Hao Ying, Chandramouli Nagarajan, Nicholas Francis Grigoropoulos, Yeow Tee Goh, William Hwang
Publikováno v:
Leukemia & Lymphoma. 59:2336-2341
Diffuse large B-cell lymphoma (DLBCL) is a high-grade lymphoma that requires treatment. We retrospectively analyzed the impact of time from diagnosis-to-treatment (TDT) on progression-free survival (PFS) and overall survival (OS) in 581 R-CHOP-treate
Autor:
Antonio Ledda, Marco Sanna, Gianni Tidore, Giovanni Caocci, Fausto Dore, Federica Orru, Claudio Fozza, Giorgio La Nasa, Paola Deias
Publikováno v:
Leukemia & Lymphoma. 58:2558-2564
Invasive fungal diseases (IFD) are still a leading cause of morbidity and mortality in patients with acute myeloid leukemia (AML). Glucose-6-phosphate dehydrogenase is an enzyme that leads to the production of NADPH, required to destroy microorganism
Autor:
Anne Jansen, Marcel Nijland, Jacoline E C Bromberg, Roelien H. Enting, Jeanette K. Doorduijn, Hanneke C. Kluin-Nelemans
Publikováno v:
Leukemia & Lymphoma, 58(9), 2074-2079. Informa Healthcare
Leukemia and Lymphoma, 58(9), 2074-2079. TAYLOR & FRANCIS LTD
Leukemia and Lymphoma, 58(9), 2074-2079. TAYLOR & FRANCIS LTD
Central nervous system (CNS) involvement in systemic B-cell non-Hodgkin lymphoma (B-NHL) at diagnosis (sysCNS) is rare. We investigated the outcome of 21 patients with sysCNS, most commonly diffuse large B-cell lymphoma, treated with high dose methot